Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.
Tian, Meng-Xin; Zhou, Yu-Fu; Qu, Wei-Feng; Liu, Wei-Ren; Jin, Lei; Jiang, Xi-Fei; Wang, Han; Tao, Chen-Yang; Zhou, Pei-Yun; Fang, Yuan; Ding, Zhen-Bin; Peng, Yuan-Fei; Zhou, Jian; Fan, Jia; Shi, Ying-Hong.
Cancer Immunol Immunother
; 68(8): 1369-1378, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31338558
TGF-ß1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.
Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma.
High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.
Circulating Biomarkers for Cholangiocarcinoma.
Lymphoepithelioma-Like Carcinoma in Liver.
Role of heat shock factor 1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.